Cerbios-Pharma SA, is a privately held API manufacturer founded in 1994 by the merger of BIOFERMENT SA (founded in 1976), CERNITIN SA (founded in 1975) and SAPEC SA (founded in 1979), located in Barbengo/Lugano in southern Switzerland.
cGMP APIs made by Cerbios-Pharma SA cover small molecules (Chemical Division), large molecules and probiotics (Biological Division) sold worldwide mainly to pharma companies including EU, USA and Japan.
The chemical division has specialized in the past 30 years in Reduced Folates (world leading position) but also in the manufacturing of High Potency Active Ingredients (HPAI) with a series of Vitamin D derivatives requiring sophisticated production units with high containment levels.
The Biological Division has specialized since 1976 in research, development and production of Probiotics of Pharma quality as active pharmaceutical ingredients, pharmaceutical finished products and feed additives.
On top of that, in the last 15 years, CERBIOS has acquired a vast experience with Recombinant Proteins from mammalian cells (CHO) based on a state-of-the-art platform.
Service for third parties in exclusive manufacturing is concentrated in the area of HPAI for the Chemical Division and Recombinant Proteins for the Biological Division.
Full CMC support is given to our partners in order to provide them with the supply of cGMP clinical batches, registration/validation material and commercial manufacturing. Paramount to that is the supply of all documentation required for a successful registration.